1	Modulation	modulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	E2F	E2F	_	_	_	_	_	_	_
4	complexes	complex	_	_	_	_	_	_	_
5	during	during	_	_	_	_	_	_	_
6	G0	g0	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	S	S	_	_	_	_	_	_	_
9	phase	phase	_	_	_	_	_	_	_
10	transition	transition	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	primary	primary	_	_	_	_	_	_	_
14	B-lymphocytes	b-lymphocyte	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	pocket	pocket	_	_	_	_	_	_	_
3	protein-E2F	protein-e2f	_	_	_	_	_	_	_
4	complexes	complex	_	_	_	_	_	_	_
5	are	be	_	_	_	_	_	_	_
6	convergence	convergence	_	_	_	_	_	_	_
7	points	point	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	cycle	cycle	_	_	_	_	_	_	_
11	signaling	signaling	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	present	present	_	_	_	_	_	_	_
4	report	report	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	identified	identify	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	monitored	monitor	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	pocket	pocket	_	_	_	_	_	_	_
12	protein-E2F	protein-e2f	_	_	_	_	_	_	_
13	complexes	complex	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	primary	primary	_	_	_	_	_	_	_
17	B-lymphocytes	b-lymphocyte	_	_	_	_	_	_	_
18	after	after	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	phorbol	phorbol	_	_	_	_	_	_	_
22	12-myristate	12-myristate	_	_	_	_	_	_	_
23	13-acetate	13-acetate	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Consistent	consistent	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	previous	previous	_	_	_	_	_	_	_
4	data	datum	_	_	_	_	_	_	_
5	from	from	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	mouse	mouse	_	_	_	_	_	_	_
9	fibroblasts	fibroblast	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	T-lymphocytes	t-lymphocyte	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	E2F4	e2f4	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	DP1	dp1	_	_	_	_	_	_	_
16	form	form	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	predominant	predominant	_	_	_	_	_	_	_
19	E2F	e2f	_	_	_	_	_	_	_
20	heterodimers	heterodimer	_	_	_	_	_	_	_
21	both	both	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	G0	G0	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	G1	g1	_	_	_	_	_	_	_
26	phases	phase	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	human	human	_	_	_	_	_	_	_
30	B-lymphocyte	B-lymphocyte	_	_	_	_	_	_	_
31	cell	cell	_	_	_	_	_	_	_
32	cycle	cycle	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	whereas	whereas	_	_	_	_	_	_	_
35	E2F1	E2F1	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	-3	-3	_	_	_	_	_	_	_
38	are	be	_	_	_	_	_	_	_
39	first	first	_	_	_	_	_	_	_
40	detected	detect	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	late	late	_	_	_	_	_	_	_
43	G1	g1	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	their	their	_	_	_	_	_	_	_
47	expression	expression	_	_	_	_	_	_	_
48	levels	level	_	_	_	_	_	_	_
49	increase	increase	_	_	_	_	_	_	_
50	towards	towards	_	_	_	_	_	_	_
51	S	S	_	_	_	_	_	_	_
52	phase	phase	_	_	_	_	_	_	_
53	.	.	_	_	_	_	_	_	_

1	Intriguingly	intriguingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	major	major	_	_	_	_	_	_	_
5	E2F	e2f	_	_	_	_	_	_	_
6	complex	complex	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	we	we	_	_	_	_	_	_	_
9	detected	detect	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	quiescent	quiescent	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	B-lymphocytes	b-lymphocyte	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	consisted	consist	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	pRB	pRB	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	E2F4	E2F4	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	DP1	DP1	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Though	though	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	DP1	DP1	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	-2	-2	_	_	_	_	_	_	_
8	increase	increase	_	_	_	_	_	_	_
9	when	when	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	progress	progress	_	_	_	_	_	_	_
12	from	from	_	_	_	_	_	_	_
13	G0	g0	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	S	S	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	proportion	proportion	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	DP1	dp1	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	DP2	dp2	_	_	_	_	_	_	_
23	remains	remain	_	_	_	_	_	_	_
24	relatively	relatively	_	_	_	_	_	_	_
25	constant	constant	_	_	_	_	_	_	_
26	during	during	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	cycle	cycle	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	observed	observe	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	increase	increase	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	electrophoretic	electrophoretic	_	_	_	_	_	_	_
8	mobility	mobility	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	predominant	predominant	_	_	_	_	_	_	_
12	E2F	e2f	_	_	_	_	_	_	_
13	components	component	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	DP1	DP1	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	E2F4	E2F4	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	B-lymphocytes	b-lymphocyte	_	_	_	_	_	_	_
21	progressed	progress	_	_	_	_	_	_	_
22	from	from	_	_	_	_	_	_	_
23	G0	g0	_	_	_	_	_	_	_
24	into	into	_	_	_	_	_	_	_
25	early	early	_	_	_	_	_	_	_
26	G1	g1	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	increase	increase	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	mobility	mobility	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	attributable	attributable	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	dephosphorylation	dephosphorylation	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	lambda	lambda	_	_	_	_	_	_	_
12	phosphatase	phosphatase	_	_	_	_	_	_	_
13	treatment	treatment	_	_	_	_	_	_	_
14	could	could	_	_	_	_	_	_	_
15	convert	convert	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	slower	slow	_	_	_	_	_	_	_
18	migrating	migrating	_	_	_	_	_	_	_
19	forms	form	_	_	_	_	_	_	_
20	into	into	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	corresponding	correspond	_	_	_	_	_	_	_
23	faster	fast	_	_	_	_	_	_	_
24	mobility	mobility	_	_	_	_	_	_	_
25	forms	form	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	further	further	_	_	_	_	_	_	_
3	demonstrated	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	this	this	_	_	_	_	_	_	_
6	change	change	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	phosphorylation	phosphorylation	_	_	_	_	_	_	_
9	status	status	_	_	_	_	_	_	_
10	correlates	correlate	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	decrease	decrease	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	DNA	DNA	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	modulation	modulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	DNA	DNA	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	mediated	mediate	_	_	_	_	_	_	_
8	through	through	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	dephosphorylation	dephosphorylation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	DP1	DP1	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	E2F4	E2F4	_	_	_	_	_	_	_
15	could	could	_	_	_	_	_	_	_
16	help	help	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	explain	explain	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	lack	lack	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	vivo	vivo	_	_	_	_	_	_	_
24	DNA	dna	_	_	_	_	_	_	_
25	footprinting	footprinting	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	late	late	_	_	_	_	_	_	_
28	G1	G1	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	S	S	_	_	_	_	_	_	_
31	phases	phase	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	gene	gene	_	_	_	_	_	_	_
34	promoters	promoter	_	_	_	_	_	_	_
35	negatively	negatively	_	_	_	_	_	_	_
36	regulated	regulate	_	_	_	_	_	_	_
37	through	through	_	_	_	_	_	_	_
38	E2F	E2F	_	_	_	_	_	_	_
39	sites	site	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	suggests	suggest	_	_	_	_	_	_	_
42	a	a	_	_	_	_	_	_	_
43	novel	novel	_	_	_	_	_	_	_
44	mechanism	mechanism	_	_	_	_	_	_	_
45	for	for	_	_	_	_	_	_	_
46	controlling	control	_	_	_	_	_	_	_
47	E2F	E2F	_	_	_	_	_	_	_
48	transcriptional	transcriptional	_	_	_	_	_	_	_
49	activity	activity	_	_	_	_	_	_	_
50	during	during	_	_	_	_	_	_	_
51	the	the	_	_	_	_	_	_	_
52	transition	transition	_	_	_	_	_	_	_
53	from	from	_	_	_	_	_	_	_
54	quiescence	quiescence	_	_	_	_	_	_	_
55	to	to	_	_	_	_	_	_	_
56	proliferation	proliferation	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

